Are there any precautions to take while using EIKANCE (0.01% Atropine Sulfate Eye Drops)?

During useEIKANCE (0.01% Atropine Sulfate Eye Drops), patients need to pay special attention to the following aspects to ensure the effectiveness and safety of the drug.

This eye drop is mainly used for 4 to 14 years old, with myopic spherical lens power between -1.00D to -4.00D, with astigmatism ≤1.50D and anisometropia ≤1.50D. Patients beyond this range should consult a physician before use.

It is contraindicated in patients with glaucoma or a tendency to glaucoma, and those allergic to hyoscyamine alkaloids or any ingredients in the eye drops.

People with low regulation ability and hypopigmentation (such as albinism) should use it with caution. Some eye diseases (such as keratitis) accompanied by photophobia symptoms can be used after recovery.

The method of use of eye drops is 1 times a day, 1 drops each time, and instill them into the conjunctival sac before going to bed. Clean your hands before use to avoid contaminating the bottle mouth and liquid. After eye drops, the medial canthus lacrimal sac should be gently compressed for 2-3 minutes to reduce systemic absorption of the drug and reduce adverse reactions. Then rest with your eyes closed for about 5 minutes, and wipe away the spilled liquid with a clean tissue.

Temporary eye irritation may occur after use. If it can be relieved within 2-3 minutes and can be tolerated, there is no need to stop the medication. If irritation symptoms persist or worsen, discontinue medication immediately and consult a doctor.

Patients may experience photophobia or squinting in bright environments, and blurry vision, especially when looking close. These symptoms usually gradually reduce or disappear as the medication is prolonged. If it affects your daily life, you can consult your doctor to adjust your medication plan.

EIKANCEEye drops are auxiliary drugs that delay the progression of myopia and require long-term use to see the effect. However, you should receive regular eye examinations during use to monitor myopia and eye conditions. If the effect is not good or adverse reactions occur, the treatment plan should be adjusted under the guidance of a doctor and should not be replaced by atropine eye drops of higher concentration on your own.

This eye drop is a prescription drug and must be used under the guidance of a doctor. During the period of medication, good eye-use habits should be maintained, such as reducing the time of using eyes at close range, increasing the time of outdoor activities, etc., to comprehensively prevent and control myopia.